MiMedx Group Inc
NASDAQ:MDXG

Watchlist Manager
MiMedx Group Inc Logo
MiMedx Group Inc
NASDAQ:MDXG
Watchlist
Price: 6.39 USD -0.62%
Market Cap: 941.7m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+42%
Revenue
Forecast
N/A
Operating Income
Forecast
+19%
Net Income
Forecast
N/A

Wall Street
Price Targets

MDXG Price Targets Summary
MiMedx Group Inc

Wall Street analysts forecast MDXG stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MDXG is 12.24 USD with a low forecast of 11.11 USD and a high forecast of 13.65 USD.

MDXG Lowest Forecast
Wall Street Target
11.11 USD
74% Upside
MDXG Average Forecast
Wall Street Target
12.24 USD
92% Upside
MDXG Highest Forecast
Wall Street Target
13.65 USD
114% Upside
Lowest
Price Target
11.11 USD
74% Upside
Average
Price Target
12.24 USD
92% Upside
Highest
Price Target
13.65 USD
114% Upside
MiMedx Group Inc Competitors:
Price Targets
EDIT
Editas Medicine Inc
101% Upside
GNS
Genus PLC
24% Upside
ELUT
Elutia Inc
335% Upside
BCYC
Bicycle Therapeutics PLC
217% Upside
EDIT
Editas Medicine Inc
101% Upside
GNS
Genus PLC
24% Upside
ELUT
Elutia Inc
335% Upside
BCYC
Bicycle Therapeutics PLC
217% Upside
P
000403
Pacific Shuanglin Bio pharmacy Co Ltd
24% Upside
CSL
CSL Ltd
31% Upside
AVTE
Aerovate Therapeutics Inc
11% Downside
GMAB
Genmab A/S
47% Upside

Revenue
Forecast

Revenue Estimate
MiMedx Group Inc

For the last 8 years the compound annual growth rate for MiMedx Group Inc's revenue is 6%. The projected CAGR for the next 3 years is 10%.

6%
Past Growth
10%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
MiMedx Group Inc

For the last 8 years the compound annual growth rate for MiMedx Group Inc's operating income is 46%. The projected CAGR for the next 3 years is 13%.

46%
Past Growth
13%
Estimated Growth
Estimates Accuracy
-56%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
MiMedx Group Inc

For the last 8 years the compound annual growth rate for MiMedx Group Inc's net income is 79%. The projected CAGR for the next 3 years is 8%.

79%
Past Growth
8%
Estimated Growth
Estimates Accuracy
-7%
Average Miss
What are analyst estimates?

See Also

Summary
MDXG intrinsic value, competitors valuation, and company profile.
DCF Valuation
MDXG stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MDXG stock valuation using valuation multiples.
Wall Street Estimates
MDXG price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MDXG stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MDXG's stock price target?
Price Target
12.24 USD

According to Wall Street analysts, the average 1-year price target for MDXG is 12.24 USD with a low forecast of 11.11 USD and a high forecast of 13.65 USD.

What is MiMedx Group Inc's Revenue forecast?
Projected CAGR
10%

For the last 8 years the compound annual growth rate for MiMedx Group Inc's revenue is 6%. The projected CAGR for the next 3 years is 10%.

What is MiMedx Group Inc's Operating Income forecast?
Projected CAGR
13%

For the last 8 years the compound annual growth rate for MiMedx Group Inc's operating income is 46%. The projected CAGR for the next 3 years is 13%.

What is MiMedx Group Inc's Net Income forecast?
Projected CAGR
8%

For the last 8 years the compound annual growth rate for MiMedx Group Inc's net income is 79%. The projected CAGR for the next 3 years is 8%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 259,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.